Will Mounjaro's price come down — and what drives UK costs right now?

The myth worth correcting: prices were on their way down

A number of sources floated the idea over 2024 that Mounjaro's private price would ease as supply improved. If you've been wondering whether Mounjaro prices are going down, the short answer is that the opposite happened. Eli Lilly adjusted its UK list pricing upward from 1 September 2025, the highest dose's list price moved from around £122 to around £330 per four-week pen, as widely reported at the time. Private clinics and pharmacies price above list to cover the clinical infrastructure that a prescription-only medicine legally requires: prescriber time, pharmacy overheads, dispensing checks. The result is that the market ceiling rose, and there is no credible signal pointing to a meaningful reversal in the short term.

That doesn't mean every provider charges the same. Prices vary by dose, by service model, and by what's actually included. Understanding that gap is where the more useful question lives. You can read a fuller breakdown of how Mounjaro pricing in the UK is structured if you want the detail on what moves the number.

What headline prices often leave out

The figures quoted on comparison sites and in press coverage tend to be treatment-only numbers. The real cost of a clinically sound private prescription includes the consultation (some providers charge £20–£50 separately), the prescription fee itself, delivery, and access to clinical support if something doesn't feel right mid-treatment. Strip those out and a low figure looks attractive. Add them back and the gap between providers narrows considerably, and sometimes reverses.

There's also the question of what happens at repeat. Some services issue the initial prescription cheaply and charge more for ongoing clinical reviews, or bundle you into a subscription that auto-renews. For anyone asking whether Mounjaro has come down in price over time, the full annual cost rather than just the first month gives a more honest picture. Our frequently asked questions covers what repeat orders involve at nume, if that's useful context.

For a wider look at weight-loss treatments and what the consultation process involves, that page walks through the options alongside what clinical assessment looks like in practice.

Where nume sits, plainly stated

We are not the cheapest option. That is a deliberate decision, not an oversight. One price covers everything: consultation, prescription, treatment, and free next-working-day tracked delivery. There are no add-on fees and no subscription. Every repeat order gets a full clinical re-review before anything is dispensed, because a prescription medicine should be looked at by a prescriber each time, not processed automatically.

Our prescribers (you can read about our clinical team) are GPhC-registered Independent Prescribers. Orders placed before 12pm Monday to Friday are reviewed the same day and dispatched once approved, arriving the next working day via DPD. The pharmacy holding those medicines is GPhC-registered; the registration number is 9012878, verifiable on the GPhC register. That transparency is intentional.

If you'd like to check whether you meet the clinical criteria, the right step is a free consultation with our prescribers. Eligibility isn't just about BMI, the full clinical picture matters, and a prescriber makes that call, not a tick-box.

Why the cheapest listing is the wrong place to look

Mounjaro is a Prescription-Only Medicine. The NHS guidance on tirzepatide is clear that these medicines require clinical assessment; they are not assessed for quick or cosmetic weight loss, as the MHRA has stated publicly. That regulatory reality means that any seller offering them at prices far below the market, without clear evidence of a prescriber-led process, is a red flag, not a deal.

The MHRA has warned repeatedly about counterfeit and illegally traded weight-loss pens sold online. Fake pens have been found to contain the wrong substances entirely. Reporting a suspect seller takes under two minutes via the MHRA Yellow Card scheme, and it protects other buyers too. For any online pharmacy, the GPhC register is the check worth doing before you order anything. A price that seems to have beaten the market probably has, just not in a way that benefits you.

The honest answer to whether Mounjaro will come down in price: not soon, and not in a way that changes the calculation for someone weighing clinical safety against cost. Those also asking whether the price of Mounjaro is going down or whether Mounjaro is going up in price will find that the direction of travel has, so far, been upward. The more productive frame is whether the service behind the price is one you can trust. That's the question our approach at nume is built around.